期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肾移植后并发晚发型淋巴组织增生性疾病一例

原文传递
导出
摘要 移植后淋巴组织增生性疾病（PTLD）是实体器官或造血干细胞移植后的一种严重并发症。文献显示，PTLD的总发生率不足2％，肾移植后PTLD发生率约1％。PTLD常发生于肾移植后1年内，也可在10年后发生。我科收治1例肾移植后晚发型PTLD，报告如下。
作者 刘增波 杨剑辉 于瑞发 马增翼 李丽 李军凯 韩志双 丰爱梅
机构地区 解放军第四五六医院肾内科 解放军第四五六医院肿瘤治疗中心
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2009年第10期633-634,共2页 Chinese Journal of Organ Transplantation
关键词 移植后淋巴组织增生性疾病 严重并发症 晚发型 肾 造血干细胞 发生率
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献14

  • 1Dharnidharka VR,Tejani AH,Ho PL,et al.Post-transplant lymphoproliferative disorder in the United States:young Caucasian males are at highest risk.Am J Transplant,2002,2(10):993-998.
  • 2Caillard S,Lelong C,Pessione F,et al.Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults:report of 230 cases from the French Registry.Am J Transplant,2006,6(11):2735-2742.
  • 3Ghobrial IM,Habermann TM,Macon WR,et al.Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients;are they two different diseases? Transplantation,2005,79(2):244-247.
  • 4A predictive model for aggressive non-Hodgkin's lymphoma.The International Non-Hodgkin's Lymphoma Prognostic Factors Project.N Engl J Med,1993,329(14):987-994.
  • 5Dharnidharka VR,Sullivan EK,Stablein DM,et al.Risk factors for posttransplant lymphoproliferative disorder (PTLD)in pediatric kidney transplantation:a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).Transplantation,2001,71(8):1065-1068.
  • 6Funch DP,Brady J,Ko HH,et al.Methods and objectives of a large US multicenter case-control study of post-transplant lymphoproliferative disorder in renal transplant patients.Recent Results Cancer Res,2002,159:81-88.
  • 7Guba M,Graeb C,Jauch KW,et al.Pro-and anti-cancer effects of immunosuppressive agents used in organ transplantation.Transplantation,2004,77(12):1777-1782.
  • 8Wimmer CD,Rentsch M,Crispin A,et al.The janus face of immunosuppression-de novo malignancy after renal transplantation:the experience of the Transplantation Center Munich.Kidney Int,2007,71(12):1271-1278.
  • 9Tsai DE,Hardy CL,Tomaszewski JE,et al.Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder:analysis of prognostic variables and long-term follow-up of 42 adult patients.Transplantation,2001,71(8):1076-1088.
  • 10黄刚,陈立中.几种具有抗肿瘤作用的免疫抑制剂[J].中华器官移植杂志,2006,27(6):382-384. 被引量：3

二级参考文献27

  • 1王长希,刘龙山,陈立中,吴培根,费继光,邱江,邓素雄,郑克立,纪玉莲,朱兰英,沈清瑞,何晓顺.雷帕霉素治疗肾移植术后肿瘤八例[J].中华器官移植杂志,2005,26(5):278-279. 被引量：8
  • 2Xu X, Shen J, Mall JW, et al. In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action. Biochem Pharmacol, 1999,58:1405-1413.
  • 3Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl, 1998,12:147-158.
  • 4Aoki M, Blazek E, Vogt PK. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.Proc Natl Acad Sci USA, 2001,98:136-141.
  • 5Majewski M, Korecka M, Joergensen J, et al. Immunosuppressire TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Transplantation, 2003, 75:1710-1717.
  • 6Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis:involvement of vascular endothelial growth factor. Nat Med,2002, 8:128-135.
  • 7Luan FL, Ding R, Sharma VK, et al. Raparaycin is an effective inhibitor of human renal cancer metastasis. Kidney Int, 2003,63:917-926.
  • 8Koehl G, Guba M, Seeliger H, et al. Rapamycin treatment at immunosuppressive doses affects tumor blood vessel circulation.Transplant Proc, 2003,35:2135-2136.
  • 9Luan FL, Hojo M, Maluccio M, et al. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation ,2002, 73:1565-1572.
  • 10Nourse J, Firpo E, Flanagan WM, et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamyein. Nature ,1994, 372:570-573.

共引文献2

中华器官移植杂志
2009年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部